Results 1 to 10 of about 128,798 (260)

Chronic Diseases and Influenza Vaccines. [PDF]

open access: yesVaccines (Basel)
Background: Chronic illnesses pose a major global health challenge with an estimated 1.56 billion people affected worldwide in 2025, and 85% of these being older adults facing at least one chronic condition.
Lian R, Zhang H, An Y, Chen Z.
europepmc   +2 more sources

Influenza Vaccines

open access: yesNature Reviews Drug Discovery, 2006
Mark J, Belsey   +3 more
europepmc   +3 more sources

Vaccines for Influenza [PDF]

open access: yesVaccines, 2021
Two reviews by Harding and Heaton [...]
Effie-Photini Tsilibary   +2 more
openaire   +3 more sources

Influenza vaccines [PDF]

open access: yesVaccine, 2009
Influenza A viruses pose a substantial threat to the human population whether by purposeful manipulation and release or by the natural process of interspecies transmissions from animal reservoirs. The challenge with preparing for these events with vaccination strategies is that the best forms of protective immunity target the most variable of the viral
A H, Ellebedy, R J, Webby
openaire   +4 more sources

Influenza and the influenza vaccine [PDF]

open access: yesCanadian Medical Association Journal, 2007
Influenza, or the “flu,” is an infection caused by the influenza virus. The virus infects the nose and throat, and it can sometimes spread to the lungs. Influenza commonly causes acute fever, cough, chills, tiredness, body aches and, in young children, ear aches.
Noni, MacDonald   +2 more
openaire   +2 more sources

Influenza and Influenza Vaccine: A Review [PDF]

open access: yesJournal of Midwifery & Women's Health, 2021
AbstractInfluenza is a highly contagious, deadly virus, killing nearly half a million people yearly worldwide. The classic symptoms of influenza are fever, fatigue, cough, and body aches. In the outpatient setting, diagnosis can be made by clinical presentation with optional confirmatory diagnostic testing.
Cynthia Nypaver   +2 more
openaire   +2 more sources

Nucleoprotein as a Promising Antigen for Broadly Protective Influenza Vaccines

open access: yes, 2023
Annual vaccination is considered as the main preventive strategy against seasonal influenza. Due to the highly variable nature of major viral antigens, such as hemagglutinin (HA) and neuraminidase (NA), influenza vaccine strains should be regularly ...
Irina Isakova-Sivak   +2 more
core   +1 more source

Influenza vaccination

open access: yesNursing Older People, 1999
Nurses have an important part to play in dispelling myths about influenza vaccination and in actively encouraging older people to attend for vaccination. Irene Schofield discusses the issues.
A, Uma, P, Thirumalaikolundusubramanian
openaire   +5 more sources

Improved adjuvanting of seasonal influenza vaccines: Pre-clinical studies of MVA-NP+M1 co-administration with inactivated influenza vaccine. [PDF]

open access: yes, 2013
Licensed seasonal influenza vaccines induce antibody responses against influenza hemagglutinin that are limited in their ability to protect against different strains of influenza.
Gilbert, SC   +36 more
core   +1 more source

The Next Generation of Influenza Vaccines: Towards a Universal Solution

open access: yes, 2021
Influenza viruses remain a constant burden in humans, causing millions of infections and hundreds of thousands of deaths each year. Current influenza virus vaccine modalities primarily induce antibodies directed towards the highly variable head domain of
Daniel Watterson   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy